期刊文献+

ALDH1和上皮间质转化相关蛋白在三阴性乳腺癌中的表达及其相关性 被引量:4

Expression of ALDH1 and Epithelial-mesenchymal Transition-related Proteins in Triple Negative Breast Cancer and Their Correlations
原文传递
导出
摘要 [目的]探讨三阴性乳腺癌(TNBC)组织中乙醛脱氢酶1(ALDH1)和上皮间质转化(EMT)相关蛋白的表达情况及其相关性。[方法]采用免疫组化方法检测90例TNBC组织中ALDH1以及EMT相关蛋白E-钙黏蛋白(E-cad)、N-钙黏蛋白(N-cad)的表达,分析其与临床病理特征的关系,并进一步分析ALDH1和EMT相关蛋白之间的相关性。[结果]TNBC组织中ALDH1、E-cad、N-cad的阳性表达率分别为45.6%(41/90)、56.7%(51/90)、52.2%(47/90)。淋巴结转移在不同ALDH1表达组间差异具有统计学意义(P<0.05),肿瘤大小、组织学分级、淋巴结转移在不同E-cad表达组间差异具有统计学意义(P<0.05),组织学分级、淋巴结转移在不同N-cad表达组间差异具有统计学意义(P<0.05)。ALDH1的表达与E-cad、N-cad的表达均相关(P<0.001),E-cad的表达与N-cad的表达也呈弱的负相关(r=-0.208,P=0.049)。[结论]TNBC组织中EMT参与了乳腺癌的发生、浸润、转移,并且能够增加乳腺癌组织中的干细胞表型。 [Purpose] To investigate the expressions of aldehyde dehydrogenase 1(ALDH1) and epithelial-mesenchymal transition(EMT)-related proteins in triple negative breast cancer(TNBC)and their correlations.[Methods] The expressions of ALDH1,E-cadherin(E-cad),N-cadherin(N-cad) in 90 cases with TNBC were detected immunohistochemically.The relationship between the expressions of ALDH1,E-cadherin,N-cadherin and the clinicopathological characteristics was analyzed.The correlation between ALDH1 and EMT-related proteins was also analyzed.[Results] The positive rate of ALDH1,E-cad,N-cad was 45.6%(41/90),56.7%(51/90),52.2%(47/90) respectively in TNBC.The lymph node metastasis was significantly different between the positive and negative expression groups of ALDH1.The tumor size,histological grade,lymph node metastasis were significantly different between the positive and negative expression groups of E-cad.The histological grade,lymph node metastasis were significantly different between the positive and negative expression groups of N-cad.The expression of ALDH1 strongly correlated with the expressions of E-cad and N-cad(P0.001).The expressions between E-cad and N-cad showed weak correlation(r=-0.208,P=0.049).[Conclusion] EMT is involved in the occurrence,invasion and metastasis of TNBC and also increases the stem cell phenotype in the breast cancer tissue.
机构地区 江苏省肿瘤医院
出处 《肿瘤学杂志》 CAS 2013年第5期369-372,共4页 Journal of Chinese Oncology
基金 江苏省"333高层次人才培养工程"科研项目资助
关键词 乳腺肿瘤 乙醛脱氢酶1(ALDH1) 上皮间质转化 免疫组织化学 breast neoplasms aldehyde dehydrogenase 1(ALDH1) epithelial-mesenchymal transition immunohistochemistry
  • 相关文献

参考文献13

  • 1Hennessy BT, Gonzalez-Angulo AM,Stemke-Hale K,et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics[J]. Cancer Res,2009,69(10): 4116-4124.
  • 2Hermann PC,Bhaskar S,Cioffi M,et al. Cancer stem cellsin solid tumors[J]. Semin Cancer Biol,2010,20(2): 77-84.
  • 3AI-Hajj M,Wicha MS, Benito-Hernandez A,et al. Prospec- tive identification of tumorigenic breast cancer cells [J]. Proe Natl Aead Sei U S A,2003,100(7): 3983-3988.
  • 4Ginestier C,Hur MH,Charafe-Jauffret E,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J]. Cell Stem Cell ,2007,1(5): 555-567.
  • 5Morel AP, Li:vre M ,Thomas C ,et al. Generation of breast eaneer stem cells through epithelial-mesenehymal transi- tion[J]. PLoS One, 2008,3(8): e2888.
  • 6Singhai R,Patil VW,Jaiswal SR,et al. E-cadherin as a diagnostic biomarker in breast cancer[J]. N Am J Med Sei, 2011,3(5): 227-233.
  • 7Thiery JP. Epithelial-mesenchymal transitions in tumour progression[J]. Nat Rev Cancer,2002,2(6): 442-454.
  • 8Mani SA,Guo W, Liao MJ,et al. The epithelial-mesenchy- mal transition generates cells with properties of stem cells [J]. Cell, 2008,133(4): 704-715.
  • 9Santisteban M,Reiman JM,Asiedu MK,et al. Immune-in- duced epithelial to mesenchymal transition in vivo genera-tes breast cancer stem cells[J]. Cancer Res,2009,69(7): 2887-2895.
  • 10Sarri6 D, Rodfiguez-Pinilla SM, Hardisson D,et al. Epithe- lial-mesenchymal transition in breast canc.er relates to the basal-like phenotype[J]. Cancer Res,2008,68(4): 989-997.

二级参考文献11

  • 1Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci USA, 2003,100(7):3983-3988.
  • 2Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/ progenitor cell properties [J]. Cancer Res, 2005, 65(13): 5506-5511.
  • 3Sheridan C, Kishimoto H, Fuchs RK, et al. CD44^+/CD24^- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis [J]. Breast Cancer Res, 2006, 8(5):R59.
  • 4Abraham BK, Fritz P, McClellan M, et al. Prevalence of CD44^+/CD24^/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis [J]. Clin Cancer Res, 2005, 11(3):1154-1159.
  • 5Shipitsin M, Campbell LL, Argani P, et al. Molecular definition of breast tumor heterogeneity [J]. Cancer Cell,2007, 11 (3):259-273.
  • 6Thiery JP. Epithelial-mesenchymal transitions in tumour progression[J]. Nat Rev Cancer, 2002, 2(6):442-454.
  • 7Chagraoui J, Lepage-Noll A, Anjo A, et al. Fetal liver stroma consists of cells in epithelial-to-mesenchymal transition[J]. Blood, 2003, 101(8):2973-2982.
  • 8Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis[J]. Cell, 2004, 117(7):927-939.
  • 9Baumann P, Cremers N, Kroese F, et al. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis [J]. Cancer Res, 2005, 65(23):10783-10793.
  • 10Mylona E, Giannopoulou I, Fasomytakis E, et al. The clinicopathologic and prognostic significance of CD44^(+)/CD24^(-/low) and CD44^(-)/CD24^(+) tumor cells in invasive breast carcinomas[J]. Hum Pathol, 2008, 39(7):1096-1102.

共引文献3

同被引文献93

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部